Clinical and economic justification of screening for mucopolysaccharidosis type I in children at groups of risks
Background. Mucopolysaccharidosis Type I (MPS I) has clinical heterogeneity without specific symptoms leading to difficulties with diagnostic on time. In-depth screening for MPS I in children has aim of early detection and timely treatment with an enzyme replacement therapy. Aim. The purpose of this...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Izdatelstvo OKI,
2021-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|